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Introduction: The emergence of infectious diseases caused by SARS-CoV-2 has resulted in more than 90,000 infections and 3,000 deaths. The coronavirus spike glycoprotein encourages the entry of SARS-CoV-2 into cells and is the main target of antivirals. SARS-CoV-2 uses ACE2 to enter cells with an affinity similar to SARS-CoV, correlated with the efficient spread of SARS-CoV-2 among humans.
Case: The need to design effective antiviral candidates to prevent COVID-19 infection has increased. In this research, the identification, evaluation, and exploration of the structure of spike glycoprotein macromolecules of SARS-CoV and SARS-CoV-2, and the effect of their binding on ACE-2. In silico studies can be utilized to observe potential components of this coronavirus [16]. Specifically, the SARS-CoV-2 spike glycoprotein is considered the main target of coronavirus which acts as a characteristic formation. 
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